Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | REN | P00797 | 15/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.47 |
| ▸ | BRD4 | O60885 | 1/20 | 0.32 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.31 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.31 |
| ▸ | IDO1 | P14902 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL499157 | 0.98 | REN (0.52) | RENCYP3A4ALDH1A1GAAL3MBTL1 | |
| SCHEMBL499038 | 0.93 | REN (0.47) | RENCYP3A4BRD4CREBBPALDH1A1 | |
| SCHEMBL3334092 | 0.92 | REN (0.57) | RENCYP3A4BRD4CREBBPALDH1A1 | |
| SCHEMBL4789610 | 0.90 | REN (0.55) | RENCYP3A4ALDH1A1GAAL3MBTL1 | |
| SCHEMBL10253693 | 0.90 | REN (0.65) | RENCYP3A4 | |
| SCHEMBL499779 | 0.90 | REN (0.55) | RENCYP3A4ALDH1A1GAAL3MBTL1 | |
| SCHEMBL499022 | 0.90 | REN (0.54) | RENCYP3A4 | |
| SCHEMBL10254125 | 0.88 | REN (0.63) | RENCYP3A4 | |
| SCHEMBL499005 | 0.88 | REN (0.52) | RENCYP3A4 | |
| SCHEMBL499177 | 0.88 | REN (0.45) | RENCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8106221-B2 | Renin inhibitors | VITAE PHARMACEUTICALS, INC. (US) | 2012-01-31 | — | — | US | claimed |
| US-8106221-B2 | Renin inhibitors | VITAE PHARMACEUTICALS, INC. (US) | 2012-01-31 | — | — | US | disclosed |